Michael R. Bristow
2015
In 2015, Michael R. Bristow earned a total compensation of $457.3K as President and Chief Executive Officer at ARCA biopharma, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,400 |
|---|---|
| Option Awards | $12,799 |
| Salary | $296,707 |
| Stock Awards | $32,225 |
| Other | $15,136 |
| Total | $457,267 |
Bristow received $296.7K in salary, accounting for 65% of the total pay in 2015.
Bristow also received $100.4K in non-equity incentive plan, $12.8K in option awards, $32.2K in stock awards and $15.1K in other compensation.
Rankings
In 2015, Michael R. Bristow's compensation ranked 11,165th out of 13,638 executives tracked by ExecPay. In other words, Bristow earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,165 out of 13,638 | 18th |
Division Manufacturing | 4,274 out of 5,190 | 18th |
Major group Chemicals And Allied Products | 1,572 out of 1,854 | 15th |
Industry group Drugs | 1,296 out of 1,528 | 15th |
Industry In Vitro and In Vivo Diagnostic Substances | 60 out of 76 | 21st |
Source: SEC filing on April 21, 2017.
Bristow's colleagues
We found two more compensation records of executives who worked with Michael R. Bristow at ARCA biopharma in 2015.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019